Welcome to the definitive (space-themed) guide to the value-based kidney care market.
In case you missed it, my first Signals article covered 3 VBC companies who then managed around 375,000 lives and over $8 billion in spend. We also talked about the larger trillion-dollar opportunity for value-based care across indications, and why kidney care has room to run.
In this post you’ll meet 11 companies in the arena who manage roughly twice as many lives and upwards of $15 billion in annual spend. This reference guide will help you get up to speed quickly on their respective journeys to improve the cost and quality of kidney care delivery in the United States.
It’s time for value-based kidney care, Signals edition!